Pharmaceutical

New Alzheimer’s disease medication approved in Japan

Eisai and BioArctic’s Leqembi is the only approved treatment that slows cognitive and functional decline in adults with Alzheimer’s.

Sep 25, 2023 - 20:00
New Alzheimer’s disease medication approved in Japan
Eisai and BioArctic’s Leqembi is the only approved treatment that slows cognitive and functional decline in adults with Alzheimer’s.
Read the original article

Tags:

Previous Article

Chromosome-scale genome sequence of Suaeda glauca sheds light on salt stress tol...

Next Article

Pierre Fabre announces another partnership to expand oncology R&D

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Takeda wins EU approval for paediatric use of Takhzyro in HAE

Takeda wins EU approval for paediatric use of Takhzyro ...

Nov 20, 2023

STAT+: Microsoft to embed AI tool for clinical documentation in Epic’s health records software

STAT+: Microsoft to embed AI tool for clinical document...

Jan 18, 2024

STAT+: Intellia plays down concerns about accidental germline transmission in CRISPR trial

STAT+: Intellia plays down concerns about accidental ge...

Aug 21, 2023